Overcoming patient reluctance to statin intolerance

Area of Science:

• Cardiology
• Pharmacology
• Clinical Medicine

Background:

• Statin therapy is crucial for preventing cardiovascular events.
• Patient reluctance and intolerance, often linked to side effects like musculoskeletal symptoms, hinder optimal statin use.
• The nocebo effect may contribute to the overestimation of statin intolerance prevalence.

Purpose of the Study:

• To review the spectrum of statin intolerance.
• To outline clinical assessment strategies for statin intolerance.
• To present a systematic approach for managing patients with statin intolerance.

Main Methods:

• Literature review on statin intolerance.
• Analysis of factors influencing statin intolerance.
• Discussion of management strategies for statin intolerance.

Main Results:

• Statin intolerance is reported in 5% to 30% of patients, potentially overestimated by the nocebo effect.
• Older age, female sex, diabetes, chronic kidney disease, and certain concomitant medications are associated with higher intolerance.
• Effective management strategies include shared decision-making, statin rechallenge, dosage titration, and alternative therapies.

Conclusions:

• Thorough clinical evaluation is essential to diagnose statin intolerance and exclude other causes of symptoms.
• A multifaceted approach, including patient-centered strategies and alternative treatments, is necessary for managing dyslipidemia when statin intolerance occurs.